Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
93.87
+2.00 (2.18%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Veradermics Market Cap
Veradermics has a market cap or net worth of $3.92 billion as of June 18, 2026.
Market Cap
3.92B
Enterprise Value
3.53B
1-Year Change
n/a
Ranking
Category
Stock Price
$93.87
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $3.92B, an increase of 196.17%. That is a compound annual growth rate of 1,824.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.92B | 2.18% |
| Jun 17, 2026 | 3.84B | 1.01% |
| Jun 16, 2026 | 3.80B | -5.53% |
| Jun 15, 2026 | 4.02B | 0.21% |
| Jun 12, 2026 | 4.01B | 1.77% |
| Jun 11, 2026 | 3.94B | 1.53% |
| Jun 10, 2026 | 3.88B | -3.05% |
| Jun 9, 2026 | 4.01B | 6.19% |
| Jun 8, 2026 | 3.77B | -1.49% |
| Jun 5, 2026 | 3.83B | -9.42% |
| Jun 4, 2026 | 4.23B | 4.64% |
| Jun 3, 2026 | 4.04B | -1.47% |
| Jun 2, 2026 | 4.10B | -3.28% |
| Jun 1, 2026 | 4.24B | 0.59% |
| May 29, 2026 | 4.22B | -1.91% |
| May 28, 2026 | 4.30B | 2.75% |
| May 27, 2026 | 4.18B | -2.31% |
| May 26, 2026 | 4.28B | 0.87% |
| May 22, 2026 | 4.25B | -2.94% |
| May 21, 2026 | 4.37B | -0.59% |
| May 20, 2026 | 4.40B | 5.25% |
| May 19, 2026 | 4.18B | -0.31% |
| May 18, 2026 | 4.19B | 0.66% |
| May 15, 2026 | 4.17B | -5.99% |
| May 14, 2026 | 4.43B | -1.00% |
| May 13, 2026 | 4.48B | 3.12% |
| May 12, 2026 | 4.34B | -2.52% |
| May 11, 2026 | 4.45B | 1.87% |
| May 8, 2026 | 4.37B | -1.59% |
| May 7, 2026 | 4.44B | -1.75% |
| May 6, 2026 | 4.52B | -4.38% |
| May 5, 2026 | 4.73B | 9.06% |
| May 4, 2026 | 4.33B | 4.22% |
| May 1, 2026 | 4.16B | 2.02% |
| Apr 30, 2026 | 4.08B | -7.09% |
| Apr 29, 2026 | 4.39B | 13.98% |
| Apr 28, 2026 | 3.85B | 3.00% |
| Apr 27, 2026 | 3.74B | 47.55% |
| Apr 24, 2026 | 2.53B | -2.04% |
| Apr 23, 2026 | 2.59B | -1.51% |
| Apr 22, 2026 | 2.63B | -4.14% |
| Apr 21, 2026 | 2.74B | -0.84% |
| Apr 20, 2026 | 2.76B | -3.04% |
| Apr 17, 2026 | 2.85B | 2.93% |
| Apr 16, 2026 | 2.77B | -7.93% |
| Apr 15, 2026 | 3.01B | 7.35% |
| Apr 14, 2026 | 2.80B | 5.09% |
| Apr 13, 2026 | 2.66B | 3.72% |
| Apr 10, 2026 | 2.57B | 14.70% |
| Apr 9, 2026 | 2.24B | 3.34% |
| Apr 8, 2026 | 2.17B | 2.35% |
| Apr 7, 2026 | 2.12B | -11.14% |
| Apr 6, 2026 | 2.38B | -0.58% |
| Apr 2, 2026 | 2.40B | 9.20% |
| Apr 1, 2026 | 2.19B | -6.92% |
| Mar 31, 2026 | 2.36B | 3.78% |
| Mar 30, 2026 | 2.27B | -7.14% |
| Mar 27, 2026 | 2.45B | -2.99% |
| Mar 26, 2026 | 2.52B | 3.04% |
| Mar 25, 2026 | 2.45B | 3.26% |
| Mar 24, 2026 | 2.37B | 2.54% |
| Mar 23, 2026 | 2.31B | 5.15% |
| Mar 20, 2026 | 2.20B | 3.48% |
| Mar 19, 2026 | 2.12B | -3.56% |
| Mar 18, 2026 | 2.20B | -3.37% |
| Mar 17, 2026 | 2.28B | 7.23% |
| Mar 16, 2026 | 2.13B | 7.86% |
| Mar 13, 2026 | 1.97B | 2.39% |
| Mar 12, 2026 | 1.93B | 1.06% |
| Mar 11, 2026 | 1.91B | 0.75% |
| Mar 10, 2026 | 1.89B | -1.31% |
| Mar 9, 2026 | 1.92B | 5.68% |
| Mar 6, 2026 | 1.81B | -0.12% |
| Mar 5, 2026 | 1.82B | 2.68% |
| Mar 4, 2026 | 1.77B | 5.04% |
| Mar 3, 2026 | 1.68B | -3.30% |
| Mar 2, 2026 | 1.74B | 1.68% |
| Feb 27, 2026 | 1.71B | 6.85% |
| Feb 26, 2026 | 1.60B | 1.75% |
| Feb 25, 2026 | 1.57B | -3.70% |
| Feb 24, 2026 | 1.64B | -2.69% |
| Feb 23, 2026 | 1.68B | 1.15% |
| Feb 20, 2026 | 1.66B | -7.93% |
| Feb 19, 2026 | 1.80B | -3.51% |
| Feb 18, 2026 | 1.87B | 5.70% |
| Feb 17, 2026 | 1.77B | 9.02% |
| Feb 13, 2026 | 1.62B | -2.21% |
| Feb 12, 2026 | 1.66B | 0.91% |
| Feb 11, 2026 | 1.64B | 8.88% |
| Feb 10, 2026 | 1.51B | 9.24% |
| Feb 9, 2026 | 1.38B | -3.77% |
| Feb 6, 2026 | 1.44B | 3.55% |
| Feb 5, 2026 | 1.39B | 4.78% |
| Feb 4, 2026 | 1.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.35B |
| Celcuity | 4.32B |
| Erasca | 4.29B |
| Oruka Therapeutics | 4.12B |
| Catalyst Pharmaceuticals | 3.84B |
| Crinetics Pharmaceuticals | 3.66B |
| Edgewise Therapeutics | 3.59B |
| ACADIA Pharmaceuticals | 3.59B |